n Taiwan, approximately one-third to one-half of the patients who have a lower extremity amputated are diabetic, 1-4 and more than half of the amputees with diabetes have peripheral vascular disease (PVD). 2 Basically, PVD is an atherosclerotic process and atherosclerosis has been associated with a variety of environmental and genetic risk factors. The renin -angiotensin -aldosterone system plays a crucial role in the cardiovascular system. 5 Angiotensin-converting enzyme (ACE), which is a zinc-containing dipeptidase located on the endothelial lining of blood vessels throughout the body, converts angiotensin I to angiotensin II and degrades bradykinin. Its converted products play important roles in the regulation of vascular tone and in the proliferation of smooth muscle cells. [6] [7] [8] The activity of plasma ACE is genetically determined by an insertion/deletion (I/D) polymorphism at intron 16 of this gene located on chromosome 17. 9 This polymorphism is caused by the presence or absence of a 287-bp alu repeat sequence. Homozygosity for the presence of this sequence is designated II; heterozygotes are termed ID; and homozygotes for the absence of the sequence are termed DD. Homozygotes of the DD genotype have been shown to have an approximately 2-fold increase in the serum concentration of ACE than homozygotes of the II genotype. 9 The DD genotype of this polymorphism is a marker for diabetic nephropathy, 5,7,10 hypertension, 5,7 renal artery stenosis, 11 cardiomyopathies, 5 and coronary and carotid atherosclerosis. 5, 7, 12, 13 The association between ACE polymorphism and coronary artery disease and ischemic cerebrovascular disease has been studied previously in the Chinese population in Taiwan, 14-17 but its association with PVD has not. The purpose of this study was to evaluate whether the ACE genotype has any association with PVD in Chinese type 2 diabetic patients in Taiwan.
n Taiwan, approximately one-third to one-half of the patients who have a lower extremity amputated are diabetic, [1] [2] [3] [4] and more than half of the amputees with diabetes have peripheral vascular disease (PVD). 2 Basically, PVD is an atherosclerotic process and atherosclerosis has been associated with a variety of environmental and genetic risk factors. The renin -angiotensin -aldosterone system plays a crucial role in the cardiovascular system. 5 Angiotensin-converting enzyme (ACE), which is a zinc-containing dipeptidase located on the endothelial lining of blood vessels throughout the body, converts angiotensin I to angiotensin II and degrades bradykinin. Its converted products play important roles in the regulation of vascular tone and in the proliferation of smooth muscle cells. [6] [7] [8] The activity of plasma ACE is genetically determined by an insertion/deletion (I/D) polymorphism at intron 16 of this gene located on chromosome 17. 9 This polymorphism is caused by the presence or absence of a 287-bp alu repeat sequence. Homozygosity for the presence of this sequence is designated II; heterozygotes are termed ID; and homozygotes for the absence of the sequence are termed DD. Homozygotes of the DD genotype have been shown to have an approximately 2-fold increase in the serum concentration of ACE than homozygotes of the II genotype. 9 The DD genotype of this polymorphism is a marker for diabetic nephropathy, 5, 7, 10 hypertension, 5, 7 renal artery stenosis, 11 cardiomyopathies, 5 and coronary and carotid atherosclerosis. 5, 7, 12, 13 The association between ACE polymorphism and coronary artery disease and ischemic cerebrovascular disease has been studied previously in the Chinese population in Taiwan, [14] [15] [16] [17] but its association with PVD has not. The purpose of this study was to evaluate whether the ACE genotype has any association with PVD in Chinese type 2 diabetic patients in Taiwan.
Methods

Subjects
A total of 361 diagnosed type 2 diabetic patients attending the outpatient clinic of the National Taiwan University Hospital were recruited consecutively. The mean age (SD) of the patients was 62.3 (11.9) years and there were 164 men and 197 women. The patients were treated with either oral anti-diabetic drugs or insulin at the time of recruitment. For those under insulin treatment, none had received that treatment within 1 year of the diagnosis of diabetes mellitus, nor did they show a history of diabetic ketoacidosis at the onset of diabetes mellitus.
Diagnosis of PVD
Diagnosis of PVD was based on an ankle -brachial index (ABI) <0.9 on either side of the lower extremities as described in our previous studies. [18] [19] [20] Doppler ultrasound (Medacord PVL, MedaSonic Inc, Mountain View, CA, USA) was used to measure the systolic pressures of the bilateral brachial, posterior tibial and dorsal pedal arteries while supine after a 20-min rest. The occluding cuffs (55×12.5 cm) were applied just above the malleoli for measurement of ankle pressures. The Doppler probe had a frequency of 8 MHz. Right and left ABI were calculated automatically by the device by dividing the higher pressure of the dorsal pedal or posterior tibial arteries on the right 
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and left sides, respectively, by the higher brachial pressure on either side.
Genomic DNA Preparation
Genomic DNA was extracted from peripheral blood as described previously. 21 Briefly, 5 ml of whole blood was mixed with 5 ml TKM1 buffer (10 mmol/L Tris-HCl, pH 7.6, 10 mmol/L KCl, 10 mmol/L MgCl2, and 2 mmol/L EDTA) and 125 l Nondet P-40. The mixture was centrifuged at 2,200 rpm for 10 min at room temperature followed by several washes with 5 ml TKM1 buffer until all the red blood cells were lysed. The TKM2 buffer (10 mmol/L TrisHCl, pH 7.6, 10 mmol/L KCl, 10 mmol/L MgCl2, 2 mmol/L EDTA, and 0.4 mol/L NaCl) and 10% sodium dodecyl sulfate were then added and incubated at 55˚C for 10 min. After adding 0.3 ml of 6 mol/L NaCl, the mixture was centrifuged at 12,000 rpm for 5 min. The supernatant was precipitated with 2 volume of 100% ethanol. After 2 washes with 70% ethanol, the DNA pellets were resuspended in an appropriate volume of TE buffer. The optical density value of 260 nm was analyzed to determine the DNA concentration.
ACE Genotyping by Polymerase Chain Reaction
The genotyping of the ACE gene was performed as described in our previous paper. 21 Briefly, the extracted DNA was subjected to polymerase chain reaction (PCR) using sense oligo 5'-CTGGAGACCACTCCCATCCTTT CT-3' and anti-sense oligo 5'-GATGTCGCCATCACATT CGTCAGAT-3' as primers in a solution containing 1.5 mmol/L MgCl2, 50 mmol/L KCl, 10 mmol/L Tris-HCl, pH 9.0, 0.1% (w/v) gelatin, 1% Triton X-100, 0.3 mmol/L each of dNTP (ProTech), 2 units Pro Taq DNA polymerase (ProTech). Approximately 500 ng to 1 g of genomic DNA was used per reaction. The PCR cycling was performed on a thermal controller with initial denaturation at 94˚C for 3 min followed by 35 cycles of 94˚C for 1 min, 58˚C for 1 min, 72˚C for 2 min and then by a final extension period at 72˚C for 7 min. Amplified DNA was separated on 2% agarose gels in the presence of ethidium bromide and separated bands were visualized over an ultraviolet-lamp.
The primers are situated outside an inserted/deleted area at intron 16 of the ACE gene, thereby giving rise to PCR products of either 490 base pairs (bp) (insertion allele) or 190 bp (deletion allele). Subjects could therefore be classified, according to the presence or absence of the insertion as II, ID or DD. The D allele has been previously shown to be preferentially amplified in heterozygotes giving rise to mis-typing of ID as DD in approximately 5% of cases. 21 To avoid this mis-typing, samples found to have DD genotype were subjected to a second independent PCR with primers that recognize an insertion-specific sequence: 5'-TGGGA CCACAGCGCCCGCCACTAC-3' as sense and 5'-TCG CCAGCCCTCCCATGCCCATAA-3' as antisense primers. The PCR reaction yields a 335 bp DNA product in the presence of the I allele. 22 
Controlled Confounders
Age, sex, body mass index (BMI), duration of diabetes, systolic and diastolic blood pressure, and history of hypertension, smoking and insulin usage were treated as possible confounders. Duration of diabetes was defined as the time period in years between the time being recruited into the study and the time diabetes was diagnosed. Blood pressure was measured on the right arm after 20 min rest on a sitting position with a mercury sphygmomanometer. The first perception of successive sounds was taken as systolic pressure and the complete disappearance of sound (Korotkoff phase V) was taken as diastolic pressure. Body weight and body height were measured with light clothes and bare feet. BMI was calculated as body weight in kilograms divided by the square of body height in meters.
Statistical Analyses
Data of continuous variables were expressed as mean ± standard deviation (SD) and categorical variables as percentage. Student's t test and chi-square test were used to compare the differences of the continuous and categorical variables, respectively, between patients with and without PVD. Logistic regression analyses were used to evaluate the odds ratios for PVD for DD vs II and ID vs II genotypes with or without the adjustment of possible confounders including age, sex, BMI, diabetes duration, smoking, hypertension, systolic and diastolic blood pressures, and insulin usage. Odds ratios and 95% confidence intervals were calculated from the regression coefficients and their standard errors. Chi-square test for categorical variables and one-way ANOVA for continuous variables were used to test the differences of PVD prevalence, demographic and clinical characteristics among the 3 groups of ACE genotypes (ie, II, ID and DD). p<0.05 was considered statistically significant. Patients with PVD also had higher prevalence of hypertension. Systolic pressure was also significantly higher in those with PVD. However, diastolic blood pressure was similar between both groups. Table 2 shows the genotype distribution and allele frequency of the ACE gene between those with PVD and those without PVD. No significant differences in the distributions of genotype or allele frequency of ACE were observed between patients with and without PVD. Table 3 compares the demographic and clinical characteristics among the 3 groups of ACE genotypes (ie, II, ID and DD). None of the characteristics differed significantly among the 3 groups by either Chi-square test or one-way ANOVA. Table 4 shows the unadjusted and adjusted odds ratios for PVD in the diabetic patients as a result of logistic regression analyses. ACE genotypes of DD vs II or ID vs II did not show significant association with PVD.
Results
Discussion
In previous studies carried out in Chinese subjects in Taiwan, there was no association of the ACE genotypes with ischemic heart disease, 14 ischemic cerebrovascular disease, 16 hypertension or type 2 diabetes mellitus with or without myocardial infarction. 15, 16 However, another study showed an association of the DD genotype with type 2 diabetes and nephropathy. 17 When we examined these previously published papers together with the present results, we found that the ACE genotypes did not associate with any form of the atherosclerotic diseases studied, including ischemic heart disease, 14, 15 ischemic cerebrovascular disease 16 and PVD (present study). This lack of an association between the deletion polymorphism and coronary heart disease was also reported in Chinese in Hong Kong. 23 Although the DD genotype has been shown to be closely associated with coronary or carotid atherosclerosis, manifesting clinically as angina, myocardial infarction or stroke, in many studies, it should be pointed out that other studies do not make a similar conclusion. 5, 7, 22 In the Physician's Health Study, a large sample of 1,250 men with ischemic heart disease and 2,340 controls were studied for the association between ACE gene polymorphism and disease risk: 22 no increased risk of ischemic heart disease or myocardial infarction was associated with the D allele. Butler et al reviewed the literature on the effect of ACE gene polymorphism on cardiovascular disease and concluded that the DD genotype appears to adversely influence specific cardiovascular diseases in specific geographical areas and in particular patient subgroups. 5 Taken together, it is possible that the effect of the ACE DD genotype on cardiovascular disease frequently observed in Caucasians is not crucial in the Chinese population. However, the possibility of a type 2 error can not be ruled out in the present study. Although the 95% confidence intervals included unity in both univariate and multivariate analyses, the odds ratios exceeded 1 ( Table 4 ). The wide confidence intervals suggested a possibility of type 2 error. Further study with a larger sample size is deemed appropriate to clarify the effect of ACE genotype on PVD.
Although Rigat et al first reported that the DD genotype was associated with an increased concentration of ACE by approximately 2-fold more than in the II genotype, 9 the mechanism underlying this quantitative difference is not known. An early hypothesis was that the deletion of the sequence in intron 16 of the ACE gene removed a transcriptional silencer, 24 but a recent study by Rosatto et al did not support this hypothesis. 25 They suggested instead that the mechanism might be referable to another locus in strict linkage disequilibrium with the I/D polymorphism of the ACE gene. It should also be pointed out that the higher ACE concentration associated with the DD genotype has not been observed in all ethnic groups. 26 In the study by Chiang et al, although the plasma ACE activity increased significantly from the II to ID and from ID to DD genotype in normal Chinese subjects in Taiwan, still there was no association between coronary artery disease and the ACE gene polymorphism. 14 The plausible explanations for a link between ACE genotype and cardiovascular disease include the influence of the genotype on vascular responsiveness to angiotensin II, an alteration in endothelial function associated with the genotype and a link between the genotype and insulin resistance. 5 For angiotensin II to exert its effect on the cardiovascular system, a proper interaction of the ligand with its receptor is necessary. Polymorphism of the angiotensin II type 1 receptor gene has been shown by Katsuya et al to be an independent risk factor for coronary artery disease. 27 The gene polymorphism has also been reported to be associated with diabetic nephropathy. 28, 29 A synergistic effect of the polymorphisms of the ACE gene and the angiotensin II type 1 receptor gene has also been reported to be a risk factor for myocardial infarction. 30 This study is probably the first to evaluate the association of the insertion/deletion polymorphism of the ACE genotypes with PVD in the Chinese population in Taiwan. The association has only rarely been studied in other ethnic groups as well; a study of German people also did not reveal any association between PVD and ACE genotypes. 31 In the analyses of other risk factors, the patients with PVD were older in age and had a longer duration of diabetes (Table 1) . They also had lower a BMI (Table 1) . It should not be misinterpreted as thinner patients have a higher risk of PVD as it actually was the older patients who tended to have a lower BMI, because age was found to correlate negatively with BMI (p<0.01). The prevalence of hypertension was higher in the patients with PVD, with borderline statistical significance (0.05<p<0.1, Table 1 ). Systolic blood pressure, rather than diastolic blood pressure, was associated with PVD in this study (Table 1) , which is in agreement with our previously published paper. 32 PVD was associated with insulin therapy (Table 1 ), but 'insulin therapy' could probably only be deemed as a surrogate marker of -cell failure in patients with a longer duration of diabetes, rather than as a cause of PVD. Neither the prevalence rates of PVD nor any of the demographic or clinical characteristics differed significantly in the 3 groups of ACE genotype (II, ID, DD) ( Table 3 ). This observation indicates that ACE genotype did not have any impact on the common risk factors of PVD.
Conclusion
The insertion/deletion genotypes (II, ID or DD) of the ACE gene located at intron 16 were not found to be associated with PVD in Chinese type 2 diabetic patients in Taiwan. However, because of the possibility of a type 2 error, further studies with larger sample size are required to clarify the effect of ACE genotype on PVD.
